Voisin Consulting Life Sciences publication icon

General Data Protection Regulation and Patients Enrolled in EU Clinical Trials

Post thumbnail General Data Protection Regulation and Patients Enrolled in EU Clinical Trials

Processing and cross-border flows of personal data significantly increased over the past decades in the EU, and it became necessary to strengthen the associated legislation. This led the European Commission to adopt the General Data Protection Regulation (GDPR (Regulation (EU) 2016/679) to protect the fundamental right of citizens to privacy with respect to the processing of their personal data, while not restricting nor prohibiting the free flow of personal data in the EU. In this article, an overview of the GDPR contributions in the framework of clinical trials in the EU, including its impact on patients’ rights, sponsors responsibilities, and patient information leaflet informed consent form, is provided.

In addition, EU citizens’ perceptions and expectations about data protection and the impact of the GDPR are discussed. Finally, the limits of the GDPR and more particularly the exemptions/derogations to patients’ rights are described.

Published on: Aug 17, 2020 
Voisin Consulting Life Sciences download icon

Download the full publication now

Fill in the form to download the content

    Yes, I would like to receive communications regarding VCLS services and events

    publication by

    Kevin Griset thumbnail
    Kevin Griset
    Senior Regulatory Scientist
    As a Senior Regulatory Scientist, Kevin is involved in various regulatory activities such as Clinical Trial Submissions, Marketing Authorisation Applications (MAA) and regulatory Life Cycle Management (LCM) activities in Europe (EU) and Switzerland.
    Charlotte Lonjaret thumbnail
    Charlotte Lonjaret
    Legal Associate, DPO